Logo image
The complicated ‘Yes’: Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors
Journal article   Peer reviewed

The complicated ‘Yes’: Decision-making processes and receptivity to lung cancer screening among head and neck cancer survivors

Aaron T Seaman, Kimberly Dukes, Richard M Hoffman, Alan J Christensen, Nicholas Kendell, Andrew L Sussman, Miriam Veléz-Bermúdez, Robert J Volk and Nitin A Pagedar
Patient education and counseling, Vol.101(10), pp.1741-1747
10/2018
DOI: 10.1016/j.pec.2018.04.012
PMCID: PMC6119119
PMID: 29709410
url
https://www.ncbi.nlm.nih.gov/pmc/articles/6119119View
Open Access

Abstract

•Qualitatively examines head and neck cancer survivors’ perspectives on lung cancer screening.•Survivors were receptive to lung cancer screening, minimizing potential harms.•They drew upon their head and neck cancer experiences as they considered screening.•Lung cancer screening discussions are complicated by head and neck cancer survivors’ history.•Specialty care settings might be more appropriate for screening discussions with this population. Shared decision making (SDM) is recommended when offering lung cancer screening (LCS)—which presents challenges with tobacco-related cancer survivors because they were excluded from clinical trials. Our objective was to characterize head and neck cancer (HNC) survivors’ knowledge, attitudes, and beliefs toward LCS and SDM. Between November 2017 and June 2018, we conducted semi-structured qualitative interviews with 19 HNC survivors, focusing on patients’ cancer and smoking history, receptivity to and perceptions of LCS, and decision-making preferences Participants were receptive to LCS, referencing their successful HNC outcomes. They perceived that LCS might reduce uncertainty and emphasized the potential benefits of early diagnosis. Some expressed concern over costs or overdiagnosis, but most minimized potential harms, including false positives and radiation exposure. Participants preferred in-person LCS discussions, often ideally with their cancer specialist. HNC survivors may have overly optimistic expectations for LCS, and clinicians need to account for this in SDM discussions. Supporting these patients in making informed decisions will be challenging because we lack clinical data on the potential benefits and harms of LCS for cancer survivors. While some patients prefer discussing LCS with their cancer specialists, the ability of specialists to support high-quality decision making is uncertain.
Practices Qualitative research Health knowledge Head and neck neoplasms Decision making Attitudes Early detection of cancer Shared Lung neoplasms

Details

Metrics

Logo image